期刊文献+

急性心肌梗死患者直接介入后无复流与血浆组织因子及组织因子途径抑制物的关系 被引量:4

Relationship of no-reflow with plasma tissue factor and tissue factor pathway inhibitor after directly intervention in patients with acute myocardial infarction
下载PDF
导出
摘要 目的通过测定急性心肌梗死(AMI)患者的血浆组织因子(TF)、组织因子途径抑制物(TFPI)水平在直接经皮冠状动脉成形术(PCI)前后的变化,研究两者与直接介入后无复流的关系。方法选择急诊行PCI的AMI患者53例,用ELISA法检测患者PCI术前、术后即刻、术后24 h外周静脉血TF、TFPI水平。根据有无复流分为无复流组与再灌流组,比较2组不同时点TF、TFPI水平的变化。结果 PCI前、PCI后即刻、PCI后24 h无复流组血浆TF、TFPI水平均明显高于再灌流组(P均<0.01);PCI后即刻,2组TF水平均较术前明显升高(P均<0.01);PCI后24 h,TF水平无复流组比术前高(P<0.05),再灌流组与术前比较差异无统计学意义(P>0.05);PCI前后2组TFPI水平比较差异均无统计学意义(P均>0.05)。结论 AMI患者直接进行PCI手术,发生无复流现象与血浆TF水平呈正相关,TFPI具有阻止血栓形成的作用,也可防治无复流现象。 Objective It is explore the relationship of no-reflow with plasma tissue factor ( TF) and tissue factor pathway inhibitor ( TFPI) by determining their changes before and after direct percutaneous coronary angioplasty ( PCI) in patients with acute myocardial infarction ( AMI) .Methods 53 patients with AMI undergoing emergency PCI were selected and the levels of plasma TF and TFPI peripheral venous blood in these patients were determined by ELISA at preoperative, postoperative time points and 24 h after PCI.The patients were divided into no-reflow group and reperfusion group according with or without re-flow, and the changes of TF and TFPI at different time point were compared between the two groups.Results The levels of plasma TF,TFPI at every time point were obviously higher in no-reflow group than that in reperfusion group (P〈0.01).The level of TF in both groups were significantly higher after PCI instantly than that before operation (P〈0.01), and the level at 24 h after operation in no-reflow group was higher than that before operation (P〈0.05), but no significant difference was found in reperfusion group (P〉0.05).There was no significant difference in TFPI level between the two groups before and after operation.Conclusion Occurrence of no-reflow is positively correlated with plasma TF level in the patients with AMI un-dergoing emergency PCI, TFPI can prevent and control the occurrence of no reflow because of its inhibiting effect of thrombo-sis.
作者 游琪
机构地区 辽宁省金秋医院
出处 《现代中西医结合杂志》 CAS 2015年第5期463-465,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 辽宁省教育厅科学研究项目(L2010555)
关键词 急性心肌梗死 经皮冠状动脉成形术 无复流 组织因子 组织因子途径抑制物 acute myocardial infarction percutaneous coronary angioplasty no reflow tissue factor tissue factor path-way inhibitor
  • 相关文献

参考文献13

  • 1Resnic FS,Wainstein M,Lee MK,et al. No-reflow is an independ- ent predictor of death and myocardial infarction after percutaneous coronary intervention [ J ]. Am Heart J,2003,145 ( 1 ) :42 - 46.
  • 2Brosh D,Assal.i AR,Mager A, et al. Effect of no-reflow during pri- mary percutaneous coronary intervention for acute myocardial infarc- tion on six-month mortality [ J ]. Am J Cardiol,2007,99 (4) :442 - 445.
  • 3Bonderman D, Teml A, Jakowitsch J, et al. Coronary no-reflow is c- aused by shedding of active tissue factor from dissected atheroscle- rotic plaques [ J ]. J Blood,2002,99 ( 8 ) :2794 - 2800.
  • 4Migdalski A,Kotschy M,Jawien A. Tissue factor, tissue factor path- way inhibitor and vascular endothelial growth factor - A in carotid atherosclerotic plaques [ J ]. Eur J Vasc Endovasc Surg, 2005,30 (1) :41 -47.
  • 5Iwakura K, Ito H, Ikushima M,et al. Association between hypergly- cemia and the no-reflow phenomenon in patients with acute myocar- dial infarction [ J ]. J Am Coil Cardiol,2003,41 ( 1 ) : 1 - 7.
  • 6Broze GJ Jr. Tissue factor pathway inhibitor and the revised theory of coagulation [ J ]. Annu Rev Med, 1995,46 : 103 - 112.
  • 7Golino P,Ragni M,Cimmino G, et al. Role of tissue factor pathway inhibitor in the regulation of tissue factor dependent blood coagula- tion [ J ]. Cardiovasc Drug Rev ,2002,20 ( 1 ) :67 - 80.
  • 8王学超.sT段抬高心肌梗死直接经皮冠脉介入治疗后心肌灌注不良的预测因素及替罗非班和山莨菪碱的保护作用[D].
  • 9河北医科大学,2012李明哲.急性心肌梗死急诊冠脉介入治疗后无复流与IL-6浓度的变化[D].吉林大学,2009.
  • 10齐晓云,杨关林,徐萍,李春华,张哲,陈岩.急性心肌梗死患者直接介入治疗后无复流与血浆组织因子的关系[J].中国心血管杂志,2008,13(3):211-212. 被引量:3

二级参考文献25

  • 1李玲,丁秋兰,王丹丹.急性心肌梗死患者组织因子及组织因子途径激活抑制物水平的变化[J].国外医学(临床生物化学与检验学分册),2005,26(7):422-423. 被引量:1
  • 2Mose JW, Leon MB,Popma J J, et al. Simdimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery [J]. N Engl J Med,2003,349( 140): 1315-1323.
  • 3Honda Y,Fitzgerald PJ. Stcnd thrombosis-an issue revisited in a changing word [J]. Circulation, 2003,108 ( 1 ) : 2-5.
  • 4Cutlip DE,Windecker S,Mehran R,et al. Clinical end points in coronary stent trials : a case for standardized definitions [ J ]. Circula- tion,2007,115(17) :2344-2351.
  • 5Stone GW,Mose JW,Ellis SG,et al. Safety and efficacy of sirolimus and paclitaxel-eluting coronary stents[J]. N Engl J Med,2007,356 (10) :998-1008.
  • 6Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents : importance of delayed healing[ J ]. Arterioscler Thromb Vasc Biol, 2007,27 ( 7 ) : 1500-1510.
  • 7Kuchulakanti PK, Chu WW,Torguson R, et al. Colt'elates and long- term outcomes of angiographically proven stent thrombosis with sitolimus and paclitaxel-eluting stents[J]. Circulation,2006,113 (8):1108-1113.
  • 8Lwaleed BA, Bass P. Tissue factor pathway inhibitor: structure,biol- ogy and involvement in disease [J]. J Pathol,2006,208 (3):327- 339.
  • 9Golino P, Ravera A, Ragni M, et al. Involvement of tissue factor path- way inhibitor in the coronary circulation of patients with acute coro- nary syndromes [ J ]. Circulation, 2003,108 (23) : 2864-2869.
  • 10Zoldhelyi P, McNatt J,Shelat HS,et al. Thromboresistance of ballnoon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor [J]. Circulation, 2000,101 (3) :289-295.

共引文献32

同被引文献33

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部